Northwestern University

University of Illinois

Ann & Robert H. Lurie Children's Hospital of Chicago

Arun K Sharma

Michael F Raterman

Ronald Hoffman

Eric Bart Sirota

Earl Y Cheng

Sherman Elias

Natalie J Fuller

Matthew I Bury

Provided herein are anti-inflammatory peptide amphiphiles (AIF-PAs) and methods of use thereof. In particular, nanofiber of AIF-PAs are provided and methods of use thereof in the treatment of inflammatory bowel diseases (e.g., Crohn's disease).

Nanomolecules for the treatment of inflammatory bowel diseases

Provided herein are anti-inflammatory nanofibers and methods of use thereof. In particular methods are provided for the use of anti-inflammatory nanofibers in the promotion of tissue (e.g., urinary bladder tissue) regeneration.

Anti-inflammatory nanofibers

Provided herein are populations of bone marrow mesenchymal stem cells (MSCs) and CD34+ hematopoietic stem/progenitor cells (HSPCs), and methods of isolation and co-administration thereof. In particular, cell populations and methods of co-administration thereof are provided for enhancing tissue (e.g., bladder) regeneration.

Isolation and co-transplantation of bone marrow mesenchymal stem cells with CD34+ hematopoietic stem/progenitor cells

This invention relates to antibodies that specific bind to fetal CD36+ cells in preference to binding to maternal CD36+ cells and methods for using these antibodies to detect and separate fetal cells from adult biological fluids including maternal peripheral blood.

Antibodies against cells of fetal origin

The present invention relates to novel human hiwi protein and genes that encode such proteins. The invention is directed toward the isolation and characterization of human hiwi proteins. The invention specifically provides isolated complementary DNA copies of mRNA corresponding to a human hiwi gene. Also provided are recombinant expression constructs capable of expressing the human hiwi gene of the invention in cultures of transformed prokaryotic and eukaryotic cells, as well as such cultures of transformed cells that synthesize the human hiwi proteins encoded therein. The invention also provides methods for isolating human hematopoietic stem cells.

Human hematopoietic growth regulatory gene product

The present invention relates to novel human hiwi protein and genes that encode such proteins. The invention is directed toward the isolation and characterization of human hiwi proteins. The invention specifically provides isolated complementary DNA copies of mRNA corresponding a human hiwi gene. Also provided are recombinant expression constructs capable of expressing the human hiwi gene of the invention in cultures of transformed prokaryotic and eukaryotic cells, as well as such cultures of transformed cells that synthesize the human hiwi proteins encoded therein. The invention also provides methods for isolating human hematopoietic stem cells.

Growing community of inventors

Elmwood Park, IL, United States of America

Arun K Sharma